276 related articles for article (PubMed ID: 27084641)
1. An Analysis of Plan Robustness for Esophageal Tumors: Comparing Volumetric Modulated Arc Therapy Plans and Spot Scanning Proton Planning.
Warren S; Partridge M; Bolsi A; Lomax AJ; Hurt C; Crosby T; Hawkins MA
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):199-207. PubMed ID: 27084641
[TBL] [Abstract][Full Text] [Related]
2. Superiority in Robustness of Multifield Optimization Over Single-Field Optimization for Pencil-Beam Proton Therapy for Oropharynx Carcinoma: An Enhanced Robustness Analysis.
Stützer K; Lin A; Kirk M; Lin L
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):738-749. PubMed ID: 29280468
[TBL] [Abstract][Full Text] [Related]
3. Comparison of organ-at-risk sparing and plan robustness for spot-scanning proton therapy and volumetric modulated arc photon therapy in head-and-neck cancer.
Barten DL; Tol JP; Dahele M; Slotman BJ; Verbakel WF
Med Phys; 2015 Nov; 42(11):6589-98. PubMed ID: 26520750
[TBL] [Abstract][Full Text] [Related]
4. Potential of Proton Therapy to Reduce Acute Hematologic Toxicity in Concurrent Chemoradiation Therapy for Esophageal Cancer.
Warren S; Hurt CN; Crosby T; Partridge M; Hawkins MA
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):729-737. PubMed ID: 29280467
[TBL] [Abstract][Full Text] [Related]
5. Dosimetric comparison of distal esophageal carcinoma plans for patients treated with small-spot intensity-modulated proton versus volumetric-modulated arc therapies.
Liu C; Bhangoo RS; Sio TT; Yu NY; Shan J; Chiang JS; Ding JX; Rule WG; Korte S; Lara P; Ding X; Bues M; Hu Y; DeWees T; Ashman JB; Liu W
J Appl Clin Med Phys; 2019 Jul; 20(7):15-27. PubMed ID: 31112371
[TBL] [Abstract][Full Text] [Related]
6. Impact of Spot Size and Spacing on the Quality of Robustly Optimized Intensity Modulated Proton Therapy Plans for Lung Cancer.
Liu C; Schild SE; Chang JY; Liao Z; Korte S; Shen J; Ding X; Hu Y; Kang Y; Keole SR; Sio TT; Wong WW; Sahoo N; Bues M; Liu W
Int J Radiat Oncol Biol Phys; 2018 Jun; 101(2):479-489. PubMed ID: 29550033
[TBL] [Abstract][Full Text] [Related]
7. Volumetric-modulated arc therapy for the treatment of a large planning target volume in thoracic esophageal cancer.
Abbas AS; Moseley D; Kassam Z; Kim SM; Cho C
J Appl Clin Med Phys; 2013 May; 14(3):4269. PubMed ID: 23652258
[TBL] [Abstract][Full Text] [Related]
8. Energy layer optimization strategies for intensity-modulated proton therapy of lung cancer patients.
Jensen MF; Hoffmann L; Petersen JBB; Møller DS; Alber M
Med Phys; 2018 Oct; 45(10):4355-4363. PubMed ID: 30129041
[TBL] [Abstract][Full Text] [Related]
9. Limited Impact of Setup and Range Uncertainties, Breathing Motion, and Interplay Effects in Robustly Optimized Intensity Modulated Proton Therapy for Stage III Non-small Cell Lung Cancer.
Inoue T; Widder J; van Dijk LV; Takegawa H; Koizumi M; Takashina M; Usui K; Kurokawa C; Sugimoto S; Saito AI; Sasai K; Van't Veld AA; Langendijk JA; Korevaar EW
Int J Radiat Oncol Biol Phys; 2016 Nov; 96(3):661-9. PubMed ID: 27681763
[TBL] [Abstract][Full Text] [Related]
10. Assessment of robustness against setup uncertainties using probabilistic scenarios in lung cancer: a comparison of proton with photon therapy.
Teoh S; George B; Fiorini F; Vallis KA; Van den Heuvel F
Br J Radiol; 2020 Mar; 93(1107):20190584. PubMed ID: 31977241
[TBL] [Abstract][Full Text] [Related]
11. Organ sparing potential and inter-fraction robustness of adaptive intensity modulated proton therapy for lung cancer.
van der Laan HP; Anakotta RM; Korevaar EW; Dieters M; Ubbels JF; Wijsman R; Sijtsema NM; Both S; Langendijk JA; Muijs CT; Knopf AC
Acta Oncol; 2019 Dec; 58(12):1775-1782. PubMed ID: 31556764
[No Abstract] [Full Text] [Related]
12. Intensity-modulated proton therapy further reduces normal tissue exposure during definitive therapy for locally advanced distal esophageal tumors: a dosimetric study.
Welsh J; Gomez D; Palmer MB; Riley BA; Mayankkumar AV; Komaki R; Dong L; Zhu XR; Likhacheva A; Liao Z; Hofstetter WL; Ajani JA; Cox JD
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1336-42. PubMed ID: 21470796
[TBL] [Abstract][Full Text] [Related]
13.
Qiu J; Lv B; Fu M; Wang X; Zheng X; Zhuo W
Head Neck; 2017 Dec; 39(12):2519-2527. PubMed ID: 28963789
[TBL] [Abstract][Full Text] [Related]
14. Volumetric-modulated arc therapy vs. c-IMRT in esophageal cancer: a treatment planning comparison.
Yin L; Wu H; Gong J; Geng JH; Jiang F; Shi AH; Yu R; Li YH; Han SK; Xu B; Zhu GY
World J Gastroenterol; 2012 Oct; 18(37):5266-75. PubMed ID: 23066322
[TBL] [Abstract][Full Text] [Related]
15. Dose-volume comparison of intensity modulated proton therapy and volumetric modulated arc therapy for cervical esophageal cancer.
Kato T; Ono T; Narita Y; Komori S; Murakami M
Med Dosim; 2022 Autumn; 47(3):216-221. PubMed ID: 35346554
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of OAR dose sparing and plan robustness of beam-specific PTV in lung cancer IMRT treatment.
Chang Y; Xiao F; Quan H; Yang Z
Radiat Oncol; 2020 Oct; 15(1):241. PubMed ID: 33069253
[TBL] [Abstract][Full Text] [Related]
17. Proton arc reduces range uncertainty effects and improves conformality compared with photon volumetric modulated arc therapy in stereotactic body radiation therapy for non-small cell lung cancer.
Seco J; Gu G; Marcelos T; Kooy H; Willers H
Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):188-94. PubMed ID: 23920395
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Robustness to Setup and Range Uncertainties for Head and Neck Patients Treated With Pencil Beam Scanning Proton Therapy.
Malyapa R; Lowe M; Bolsi A; Lomax AJ; Weber DC; Albertini F
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):154-162. PubMed ID: 27084638
[TBL] [Abstract][Full Text] [Related]
19. Advanced techniques in neoadjuvant radiotherapy allow dose escalation without increased dose to the organs at risk : Planning study in esophageal carcinoma.
Fakhrian K; Oechsner M; Kampfer S; Schuster T; Molls M; Geinitz H
Strahlenther Onkol; 2013 Apr; 189(4):293-300. PubMed ID: 23443611
[TBL] [Abstract][Full Text] [Related]
20. Dose uncertainties in IMPT for oropharyngeal cancer in the presence of anatomical, range, and setup errors.
Kraan AC; van de Water S; Teguh DN; Al-Mamgani A; Madden T; Kooy HM; Heijmen BJ; Hoogeman MS
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):888-96. PubMed ID: 24351409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
